109 related articles for article (PubMed ID: 8931930)
1. Synthesis and biochemical activity of novel amidine derivatives as m1 muscarinic receptor agonists.
Ojo B; Dunbar PG; Durant GJ; Nagy PI; Huzl JJ; Periyasamy S; Ngur DO; el-Assadi AA; Hoss WP; Messer WS
Bioorg Med Chem; 1996 Oct; 4(10):1605-15. PubMed ID: 8931930
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological characterization of 1,4,5,6-tetrahydropyrimidine and 2-amino-3,4,5,6-tetrahydropyridine derivatives as selective m1 agonists.
Messer WS; Abuh YF; Liu Y; Periyasamy S; Ngur DO; Edgar MA; El-Assadi AA; Sbeih S; Dunbar PG; Roknich S; Rho T; Fang Z; Ojo B; Zhang H; Huzl JJ; Nagy PI
J Med Chem; 1997 Apr; 40(8):1230-46. PubMed ID: 9111297
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, and neurochemical evaluation of 2-amino-5-(alkoxycarbonyl)-3,4,5,6-tetrahydropyridines and 2-amino-5-(alkoxycarbonyl)-1,4,5,6-tetrahydropyrimidines as M1 muscarinic receptor agonists.
Dunbar PG; Durant GJ; Rho T; Ojo B; Huzl JJ; Smith DA; el-Assadi AA; Sbeih S; Ngur DO; Periyasamy S
J Med Chem; 1994 Aug; 37(17):2774-82. PubMed ID: 8064804
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and muscarinic receptor activity of ester derivatives of 2-substituted 2-azabicyclo[2.2.1]heptan-5-ol and -6-ol.
Carroll FI; Abraham P; Chemburkar S; He XC; Mascarella SW; Kwon YW; Triggle DJ
J Med Chem; 1992 Jun; 35(12):2184-91. PubMed ID: 1613746
[TBL] [Abstract][Full Text] [Related]
5. Regional distribution of M1, M2 and non-M1, non-M2 subtypes of muscarinic binding sites in rat brain.
Ehlert FJ; Tran LP
J Pharmacol Exp Ther; 1990 Dec; 255(3):1148-57. PubMed ID: 2262898
[TBL] [Abstract][Full Text] [Related]
6. Multiple binding affinities of N-methylscopolamine to brain muscarinic acetylcholine receptors: differentiation from M1 and M2 receptor subtypes.
el-Fakahany EE; Ramkumar V; Lai WS
J Pharmacol Exp Ther; 1986 Aug; 238(2):554-63. PubMed ID: 3755473
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, and neurochemical evaluation of 5-(3-alkyl-1,2,4- oxadiazol-5-yl)-1,4,5,6-tetrahydropyrimidines as M1 muscarinic receptor agonists.
Dunbar PG; Durant GJ; Fang Z; Abuh YF; el-Assadi AA; Ngur DO; Periyasamy S; Hoss WP; Messer WS
J Med Chem; 1993 Apr; 36(7):842-7. PubMed ID: 8464038
[TBL] [Abstract][Full Text] [Related]
8. 6beta-Acyloxy(nor)tropanes: affinities for antagonist/agonist binding sites on transfected and native muscarinic receptors.
Daly JW; Gupta TH; Padgett WL; Pei XF
J Med Chem; 2000 Jun; 43(13):2514-22. PubMed ID: 10891110
[TBL] [Abstract][Full Text] [Related]
9. Muscarinic receptor subtype selectivity of novel heterocyclic QNB analogues.
Baumgold J; Cohen VI; Paek R; Reba RC
Life Sci; 1991; 48(24):2325-9. PubMed ID: 2046461
[TBL] [Abstract][Full Text] [Related]
10. Gallamine binding to muscarinic M1 and M2 receptors, studied by inhibition of [3H]pirenzepine and [3H]quinuclidinylbenzilate binding to rat brain membranes.
Burke RE
Mol Pharmacol; 1986 Jul; 30(1):58-68. PubMed ID: 3755217
[TBL] [Abstract][Full Text] [Related]
11. Autoradiographic analyses of agonist binding to muscarinic receptor subtypes.
Messer WS; Ellerbrock B; Price M; Hoss W
Biochem Pharmacol; 1989 Mar; 38(5):837-50. PubMed ID: 2564779
[TBL] [Abstract][Full Text] [Related]
12. Effects of agonist efficacy on desensitization of phosphoinositide hydrolysis mediated by m1 and m3 muscarinic receptors expressed in Chinese hamster ovary cells.
Hu J; Wang SZ; el-Fakahany EE
J Pharmacol Exp Ther; 1991 Jun; 257(3):938-45. PubMed ID: 1710663
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological characterization of human m1 muscarinic acetylcholine receptors with double mutations at the junction of TM VI and the third extracellular domain.
Huang XP; Williams FE; Peseckis SM; Messer WS
J Pharmacol Exp Ther; 1998 Sep; 286(3):1129-39. PubMed ID: 9732369
[TBL] [Abstract][Full Text] [Related]
14. Nicotine administration decreases the number of binding sites and mRNA of M1 and M2 muscarinic receptors in specific brain regions of rat neonates.
Zhu J; Taniguchi T; Konishi Y; Mayumi M; Muramatsu I
Life Sci; 1998; 62(12):1089-98. PubMed ID: 9519811
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo m2 muscarinic subtype selectivity of some dibenzodiazepinones and pyridobenzodiazepinones.
Cohen VI; Jin B; McRee RC; Boulay SF; Cohen EI; Sood VK; Zeeberg BR; Reba RC
Brain Res; 2000 Apr; 861(2):305-15. PubMed ID: 10760492
[TBL] [Abstract][Full Text] [Related]
16. Developmental changes in muscarinic receptor-stimulated phosphoinositide metabolism in rat brain.
Balduini W; Murphy SD; Costa LG
J Pharmacol Exp Ther; 1987 May; 241(2):421-7. PubMed ID: 3033215
[TBL] [Abstract][Full Text] [Related]
17. Agonist-induced down-regulation of m1 muscarinic receptors and reduction of their mRNA level in a transfected cell line.
Wang SZ; Hu JR; Long RM; Pou WS; Forray C; el-Fakahany EE
FEBS Lett; 1990 Dec; 276(1-2):185-8. PubMed ID: 2265699
[TBL] [Abstract][Full Text] [Related]
18. [3H]tricyclopinate binding to brain muscarinic acetylcholine receptors: a comparison with [3H]quinuclidinyl benzilate.
Gao ZG; Liu CG
Pharmacol Res; 1996; 33(4-5):283-9. PubMed ID: 8938022
[TBL] [Abstract][Full Text] [Related]
19. Regional differences in the coupling of muscarinic receptors to inositol phospholipid hydrolysis in guinea pig brain.
Fisher SK; Bartus RT
J Neurochem; 1985 Oct; 45(4):1085-95. PubMed ID: 2411866
[TBL] [Abstract][Full Text] [Related]
20. Muscarinic receptors on rat isolated colonic epithelial cells. A correlation between inhibition of [3H]quinuclidinyl benzilate binding and alteration in ion transport.
Zimmerman TW; Binder HJ
Gastroenterology; 1982 Dec; 83(6):1244-51. PubMed ID: 6127277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
